Funds and ETFs Kyowa Kirin Co. Ltd.

Equities

4151

JP3256000005

Pharmaceuticals

Market Closed - Japan Exchange 07:00:00 28/06/2024 BST 5-day change 1st Jan Change
2,748 JPY +0.83% Intraday chart for Kyowa Kirin Co. Ltd. +2.00% +15.93%

ETFs positioned on Kyowa Kirin Co. Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.02% 200 M€ +13.74% -
0.02% 35 M€ +4.82% -
0.01% 23 M€ -.--% -
0.01% 786 M€ -.--%
0.01% 36 M€ +10.49% -
0.01% 414 M€ +12.00% -
0.01% 284 M€ -.--%
0.01% 40 M€ +7.33% -
0.01% 324 M€ +8.15% -
0.01% 206 M€ -.--%
0.01% 17 M€ +3.28% -
0.01% 205 M€ -.--%
0.01% 1,166 M€ +0.26% -
0.01% 607 M€ +0.05% -
0.01% 104 M€ +5.59% -
0.01% 8 M€ +0.16% -
0.01% 32 M€ +4.52% -
0.00% 55 M€ +1.95% -
0.00% 248 M€ +14.54% -
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows: - sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment; - sales of licenses (7.4%). At the end of 2021, the group had 3 production sites located in Japan (2) and China. Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,748 JPY
Average target price
3,054 JPY
Spread / Average Target
+11.16%
Consensus
  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. Funds and ETFs Kyowa Kirin Co. Ltd.